Christina Farr

Christina Farr

Christina is an advisor to early- and late-stage healthcare companies on go-to-market strategy, storytelling, and fundraising, and shares her insights via Second Opinion. Learn more at www.chrissyfarr.com

ICHRA is gaining momentum - and if so, what does it mean for health-tech?

I teamed up with two health policy experts to explore the bull and bear case.

Christina Farr, +2

Nov 26, 2024

ICHRA is gaining momentum - and if so, what does it mean for health-tech?